Staying Focused in Frantic Times
In the midst of the pandemic, do Mercado Libre
and Avantor’s bonds offer long-term value?Charlie Houston
The value of any investment can fall as well as rise and investors may not get back the amount invested.
The onset of the pandemic spurred dramatic change across the world. Entire industries of travel, leisure and retail were upended by social distancing restrictions. Global markets tumbled before climbing to record heights. The breath-taking pace of innovation hastened the development of novel vaccines in record time.
Covid-19 has accelerated pre-existing trends with so-called pandemic beneficiaries, with ecommerce and vaccine manufacturing becoming the focus of newspaper headlines. The Nobel prize-winning economist Robert J Shiller argues that such narratives, and their variants, spread like pandemics among investors and have a causal effect on market behaviour. To deliver long-term reliable income for our clients, we seek to understand the world beyond the stories and avoid chasing hype. As ever, it is vital to calmly focus on what matters and home in on the fundamental factors driving long-term resilience of the businesses we lend to.
There are, however, two bonds that we added over the past 18 months, one in ecommerce and the other in vaccine manufacturing, that we think make great income investments – and not just for a pandemic.
The other Amazon in South America
Stories abound about the growth of ecommerce as retail shops were forced to close their doors through national lockdowns. However, Mercado Libre, the leading online marketplace in Latin America, is a case in point as to why it is worth peering beyond the headlines.
Since it was founded in the late 1990s in Argentina, Mercado Libre has expanded into 18 countries. Sales on the platform last year reached almost $21bn, triple the level of 2015. On its own, this leading ecommerce platform has been hugely successful. But what might be surprising is that this is not what we find most exciting. What makes this a resilient business to lend to for the long term?
Roughly half of Latin Americans do not have a bank account, making it difficult to manage their incomes and expenses, build savings or run small businesses. In 2014, Mercado Libre launched Mercado Pago, an online payment system which can be used by merchants via card readers, QR codes and phone wallets. Last year, Mercado Pago processed almost $50bn of payments, 10x more than in its first year. More recently, it has introduced simple consumer savings instruments and small merchant loans. While the ecommerce opportunity is on the surface for all to see, we believe the payment platform will be the driving undercurrent – and one that the market is not fully appreciating.
Mercado Libre has achieved all of this while prudently managing its funding sources and maintaining excellent liquidity. The strong balance sheet underpins its ability to pay a reliable income to bond investors. As the company grows and its revenue stream becomes more diversified, this income stream becomes more resilient, and the bonds may receive ratings upgrades and increase in price. With a current yield of over 3% and the opportunity of capital appreciation, there is more to these bonds than meets the eye.
A MercadoLibre Inc. distribution and fulfillment center in Cajamar, Sao Paulo state, Brazil.
© Bloomberg/Getty Images.
Science is magic that works
Another great success story of the pandemic has been the unprecedented pace at which scientists across the globe developed vaccines against the virus. Companies like Moderna, Pfizer and AstraZeneca, who developed some of the first successful vaccines, have dominated the front pages. But as in many great success stories, there is a crucial role played by supporting characters, which can often go unappreciated. Avantor provides a great example.
Avantor is a life sciences company that provides chemicals, materials, and specialist equipment to R&D laboratories. For over 240,000 customers worldwide, the company sources, manufactures and supplies more than six million different products, ranging from glass beakers and test tubes to the high purity chemicals required to produce novel mRNA vaccines. Increasingly, the company is playing a new support role by providing auxiliary services to laboratories, such as routine experiment preparation, freeing scientists to focus on the science.
Avantor has an integral role to play in enabling continued innovation, as a company embedded in all steps of the research process, from early-stage exploratory research and development through to production of a final therapeutic. With this long-term tailwind, Avantor has received multiple upgrades from rating agencies, rising from a B to a BB credit since our initial investment.
From superstars who are more than they seem, to unsung heroes of scientific advancement, we focus on the underlying prospects of a business, often hidden beneath short-term waves. This allows us to hand-pick opportunities missed by the wider market, driving outsized income over multiple years. Because in the long term, that is what actually matters.
Mercado Libre is held in Strategic Bond and Global Strategic Bond portfolios. Both Mercado Libre and Avantor are held in the High Yield Bond and Multi Asset Income portfolios.
The views expressed are those of the Income strategy teams and should not be considered as advice or a recommendation to buy, sell or hold a particular investment. They reflect personal opinion and should not be taken as statements of fact nor should any reliance be placed on them when making investment decisions.
Any stock examples and images used are not intended to represent recommendations to buy or sell, neither is it implied that they will prove profitable in the future. It is not known whether they will feature in any future portfolio produced by us. Any individual examples will represent only a small part of the overall portfolio and are inserted purely to help illustrate our investment style.
The following page contains information on investments which does not constitute independent research. Accordingly, it is not subject to the protections afforded to independent research and Baillie Gifford and its staff may have dealt in the investments concerned.
Past performance is not a guide to future returns.
Baillie Gifford & Co and Baillie Gifford & Co Limited are authorised and regulated by the Financial Conduct Authority (FCA). Baillie Gifford & Co Limited is an Authorised Corporate Director of OEICs.
Persons resident or domiciled outside the UK should consult with their professional advisers as to whether they require any governmental or other consents in order to enable them to invest,
and with their tax advisers for advice relevant to their own particular circumstances.
Baillie Gifford Overseas Limited is wholly owned by Baillie Gifford & Co. Baillie Gifford Overseas Limited provides investment management and advisory services to non-UK clients. Both are authorised and regulated by the Financial Conduct Authority.
Baillie Gifford Investment Management (Europe) Limited provides investment management and advisory services to European (excluding UK) clients. It was incorporated in Ireland in May 2018 and is authorised by the Central Bank of Ireland. Through its MiFID passport, it has established Baillie Gifford Investment Management (Europe) Limited (Frankfurt Branch) to market its investment management and advisory services and distribute Baillie Gifford Worldwide Funds plc in Germany. Baillie Gifford Investment Management (Europe) Limited also has a representative office in Zurich, Switzerland pursuant to Art. 58 of the Federal Act on Financial Institutions ("FinIA"). It does not constitute a branch and therefore does not have authority to commit Baillie Gifford Investment Management (Europe) Limited. It is the intention to ask for the authorisation by the Swiss Financial Market Supervisory Authority (FINMA) to maintain this representative office of a foreign asset manager of collective assets in Switzerland pursuant to the applicable transitional provisions of FinIA. Baillie Gifford Investment Management (Europe) Limited is a wholly owned subsidiary of Baillie Gifford Overseas Limited, which is wholly owned by Baillie Gifford & Co.
La presente oferta se acoge a la Norma de Carácter General N° 336 de la Comisión para el Mercado Financiero (CMF) de Chile. La presente oferta versa sobre valores no inscritos en el Registro de Valores o en el Registro deValores Extranjeros que lleva la Comisión para el Mercado Financiero, por lo que los valores sobre los cuales ésta versa, no están sujetos a su fiscalización. Que por tratarse de valores no inscritos, no existe la obligación por parte del emisor de entregar en Chile información pública respect de estos valores. Estos valores no podrán ser objeto de oferta pública mientras no sean inscritos en el Registro de Valores correspondiente.
The securities have not been, and will not be, registered with the Colombian National Registry of Securities and Issuers (Registro Nacional de Valores y Emisores) or traded on the Colombian Stock Exchange (Bolsa de Valores de Colombia). Unless so registered, the securities may not be publicly offered in Colombia or traded on the Colombian Stock Exchange. This presentation is for the sole and exclusive use of the addressee and it shall not be interpreted as being addressed to any third party in Colombia or for the use of any third party in Colombia, including any shareholders, managers or employees of the addressee. The investor acknowledges that certain Colombian laws and regulations (including but not limited to foreign exchange and tax regulations) may apply in connection with the investment in the securities and represents that is the sole liable party for full compliance therewith.
The shares have not been registered before the Superintendencia del Mercado de Valores (SVM) and are being placed by means of a private offer. SVM has not reviewed the information provided to the investor. This document is not for public distribution.
The interests in the following securities have not and will not be registered in the National Registry of Securities maintained by the National Banking and Securities Commission, and therefore may not be offered or sold publicly in Mexico. The interests in the following securities may be offered or sold to qualified and institutional investors in Mexico, pursuant to the private placement exemption set forth under Article 8 of the Securities Market Law as part of a private offer.
Information on the relevant LATAM funds is available on request. Please contact [email protected]
All information is sourced from Baillie Gifford & Co and is current unless otherwise stated.
The images used are for illustrative purposes only.
YOU MAY ALSO LIKEInsights.Visit Baillie Gifford's Insights page.A Passage for India.Whereas manufacturing once provided developing countries with a clear economic development path, robotics has made the route more challenging. Lawrence Burns explores the dilemma India now faces and suggests a possible route for its future development.Investing in Biotechnology.The starting point for investing in biotechs is science that is credible, scalable and differentiated. But that on its own does not guarantee a commercially successful business. The Health Innovation Team share their approach to investing in biotech at a time when the pace of innovation is exploding and the possibilities are endless.The S in ESG.The complexity of assessing societal impact shouldn’t deter investors from looking at a company from every angle, argues Marianne Harper Gow.